Determination of phenazopyridine in biological fluids using electromembrane extraction followed by high-performance liquid chromatography

2015 ◽  
Vol 93 (7) ◽  
pp. 702-707 ◽  
Author(s):  
Lida Fotouhi ◽  
Yadollah Yamini ◽  
Razieh Hosseini ◽  
Maryam Rezazadeh

Recently, electro-assisted extraction of ionic drugs from biological fluids through a supported liquid membrane and into an aqueous acceptor solution was introduced as a new sample preparation technique and has been termed electromembrane extraction (EME). In the present work, this microextraction technique combined with high-performance liquid chromatography and ultraviolet detection has been developed for detection of phenazopyridine (PP) as a local analgesic drug in human plasma and urine samples. From a 6.5 mL neutral aqueous sample, PP was extracted for 20 min through a thin supported liquid membrane of 2-nitrophenyl octyl ether sustained in the pores of the wall of a porous hollow fiber and into an aqueous acidic acceptor solution (25 μL, containing negative electrode) by application of a DC electrical potential. The effects of several factors, including the nature of organic solvent, HCl concentration in donor and acceptor solutions, stirring speed, extraction time, and applied voltage on the extraction efficiency of the drug, were investigated and optimized. Satisfactory linearity ranges with correlation coefficients higher than 0.996 in different extraction media, admissible limits of detection (0.5 and 1.0 ng mL−1 in urine and plasma samples, respectively) and good repeatability and reproducibility (intra- and inter-assay precisions ranged between 3.7%–6.8% and 8.8%–12.5%, respectively) were obtained. The optimized EME procedure was applied to determine the concentration of PP in various matrices, such as plasma and urine samples, and satisfactory results were obtained.

Author(s):  
Genquan Yan ◽  
Lu Yu ◽  
Xu Chen ◽  
Triet Tran ◽  
Lam Nguyen ◽  
...  

AbstractA rapid and sensitive High-Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC/MS/MS) method for determining apremilast in beagle dog plasma and urine samples was developed and validated using clopidogrel as the internal standard (IS). Apremilast was extracted from the plasma and urine samples by liquid–liquid extraction using methyl tert-butyl ether. Chromatographic separation was performed using a C8 column with gradient elution and a mobile phase containing methanol and 0.1% formic acid. Quantification was achieved in multiple reaction monitoring (MRM) mode with a transition of m/z 461.3→178.2 for apremilast and m/z 322.2→184.1 for clopidogrel (IS). This method was validated regarding its specificity, linearity, precision, accuracy, and stability. The lower limit of quantification (LLOQ) for this method was 5 ng/mL, and the calibration curve was linear over 5–1,000 ng/mL. The intra- and inter-run coefficients of variance (CV) of aprelimast in plasma samples were less than 12.92% and 10.64%, respectively, while in urine samples, the CV were less than 11.84% and 10.20%, respectively. The samples were stable under the tested conditions. This method was successfully applied to a pharmacokinetic study in beagle dogs following oral administration of 10 mg of apremilast.


Sign in / Sign up

Export Citation Format

Share Document